Epstein Secrets

arrollo Mexico Zavala SAB Jim Balsillie Chairman and Co-Chief Executive Research in Motion Limited Canada Officer Rolando Balsinde Director McKinsey & Company Spain Beat Balzli Editor-in-Chief HandelsZeitung and Switzerland Finanzrundschau AG Stephane Bancel Chief Executive Officer bioMerieux SA U

Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Development Managing Direc

Member of the Practice Committee Co-Founder Kibar Holding AS HSBC Asia Pacific Free the Children Swiss Reinsurance Company Ltd Projeto Cies McKinsey & Company Hanwha SolarOne Samsung Engineering Co. Ltd Hanwha Biologics, Hanwha Chemical Corporation Daesung Group Bridgewater Associates LP Mitsubishi C

iness School Google Inc. USA USA Germany Switzerland USA USA World Economic Forum Annual Meeting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Ola

pany oversight efforts on the firm’s healthcare information technology portfolio. Prior to joining Francisco Partners, Eric worked for three years at McKinsey & Company as a Senior Business Analyst in their Corporate Finance Practice. Eric received his dual B.A. in Mathematical Methods in the Social Sciences and Econ

) and Tioga. He was previously on the boards of Intarcia Therapuetics (now currently a Board observer), Sirna Therapeutics (NASDAQ: RNAI, acquired by Merck in 2006 for $1.1 billion), where he served as Chairman; Oriel Therapeutics (acquired by Novartis in 2010), where he served as Executive Chairman, and